Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Select Medical Holdings Co. (NYSE:SEM)

Select Medical logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 18.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 313,639 shares of the health services provider's stock after buying an additional 49,281 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.24% of Select Medical worth $5,912,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Smartleaf Asset Management LLC raised its stake in Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after buying an additional 1,473 shares during the last quarter. Covestor Ltd grew its holdings in shares of Select Medical by 33.5% in the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares during the period. Lazard Asset Management LLC increased its position in Select Medical by 47.8% during the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider's stock valued at $130,000 after acquiring an additional 2,255 shares during the last quarter. Quarry LP lifted its holdings in Select Medical by 963.0% in the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider's stock valued at $171,000 after acquiring an additional 8,224 shares during the period. Finally, HBK Investments L P bought a new position in Select Medical in the fourth quarter valued at about $188,000. 89.48% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have issued reports on SEM. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price target for the company in a research note on Monday, February 24th. Royal Bank of Canada cut their target price on shares of Select Medical from $23.00 to $19.00 and set an "outperform" rating for the company in a research report on Wednesday, May 7th. Wall Street Zen raised shares of Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Finally, Mizuho started coverage on shares of Select Medical in a research note on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat, Select Medical presently has a consensus rating of "Moderate Buy" and a consensus price target of $26.00.

Get Our Latest Stock Report on SEM

Select Medical Stock Performance

Shares of NYSE SEM traded up $0.10 during trading on Friday, hitting $15.44. The company had a trading volume of 620,371 shares, compared to its average volume of 935,096. The stock has a 50 day simple moving average of $15.76 and a 200 day simple moving average of $18.29. The firm has a market capitalization of $1.98 billion, a P/E ratio of 9.35, a price-to-earnings-growth ratio of 0.64 and a beta of 1.34. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13. Select Medical Holdings Co. has a 12 month low of $14.03 and a 12 month high of $40.98.

Select Medical (NYSE:SEM - Get Free Report) last released its earnings results on Thursday, May 1st. The health services provider reported $0.44 EPS for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a return on equity of 14.04% and a net margin of 3.23%. Select Medical's revenue was down 24.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.75 EPS. As a group, analysts anticipate that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a yield of 1.62%. The ex-dividend date was Thursday, May 15th. Select Medical's dividend payout ratio is currently 18.66%.

Select Medical declared that its board has approved a stock repurchase plan on Thursday, May 1st that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Insiders Place Their Bets

In related news, Director Parvinderjit S. Khanuja bought 21,000 shares of the company's stock in a transaction that occurred on Monday, May 5th. The stock was purchased at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the completion of the transaction, the director now owns 65,089 shares in the company, valued at $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of Select Medical stock in a transaction on Monday, April 28th. The shares were sold at an average price of $18.00, for a total transaction of $4,050,000.00. Following the completion of the sale, the chief executive officer now owns 714,516 shares in the company, valued at approximately $12,861,288. This represents a 23.95% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by company insiders.

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Recommended Stories

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Should You Invest $1,000 in Select Medical Right Now?

Before you consider Select Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Select Medical wasn't on the list.

While Select Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines